Abstract

Targeting BP below the current standard did not provide additional benefit for renal outcomes compared with standard treatment during a follow-up of 3.3 years in patients with CKD without diabetes. However, nonblack patients or those with higher levels of proteinuria might benefit from the intensive BP-lowering treatments.

Keywords

MedicineRenal functionKidney diseaseCreatinineInternal medicineBlood pressureCochrane LibraryMeta-analysisDiabetes mellitusRelative riskConfidence intervalEndocrinology

Affiliated Institutions

Related Publications

Publication Info

Year
2017
Type
review
Volume
177
Issue
6
Pages
792-792
Citations
137
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

137
OpenAlex

Cite This

Wan‐Chuan Tsai, Hon‐Yen Wu, Yu‐Sen Peng et al. (2017). Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease. JAMA Internal Medicine , 177 (6) , 792-792. https://doi.org/10.1001/jamainternmed.2017.0197

Identifiers

DOI
10.1001/jamainternmed.2017.0197